Table 2.

The Frequency of CCR5, CCR2, SDF1, and HLA Genotypes in LT-NP and Progressors

Gene or Genotype ALT (LT-NPs) n = 70 (%)IMMUNOCO (progressors) n = 83 (%) P Value
CCR5  
 Wild/mut* 26 (37)  9 (11)  .001 
CCR2  
 Wild/mut  14 (20)  13 (16)  .221 
 Mut/mut  2 (3)  0   
SDF1  
 Wild/mut 23 (33)  32 (39)  .581  
 Mut/mut  2 (3)  4 (5) 
HLA-A3  22 (31)  13 (16)  .021  
HLA-B12  13 (19) 27 (33)  .050  
HLA-B14  14 (20)  9 (11)  .114 
HLA-B17  19 (27)  11 (13)  .031  
HLA-B27  14 (20) 3 (4)  .001  
HLA-DR6  21 (30)  16 (19)  .123 
HLA-DR7  28 (40)  24 (29)  .149 
Gene or Genotype ALT (LT-NPs) n = 70 (%)IMMUNOCO (progressors) n = 83 (%) P Value
CCR5  
 Wild/mut* 26 (37)  9 (11)  .001 
CCR2  
 Wild/mut  14 (20)  13 (16)  .221 
 Mut/mut  2 (3)  0   
SDF1  
 Wild/mut 23 (33)  32 (39)  .581  
 Mut/mut  2 (3)  4 (5) 
HLA-A3  22 (31)  13 (16)  .021  
HLA-B12  13 (19) 27 (33)  .050  
HLA-B14  14 (20)  9 (11)  .114 
HLA-B17  19 (27)  11 (13)  .031  
HLA-B27  14 (20) 3 (4)  .001  
HLA-DR6  21 (30)  16 (19)  .123 
HLA-DR7  28 (40)  24 (29)  .149 
*

To simplify the presentation of results, we substituted the mutation symbols −Δ32, 64I and 3′A, by mut. Thus, the heterozygous genotype was noted as wild/mut and the homozygous genotypes were noted as wild/wild and mut/mut for each of the three screened genes.

Close Modal

or Create an Account

Close Modal
Close Modal